Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure
06/03/2025 17:39
March 6 (Reuters) - Phaxiam Therapeutics SA PHXM.PA: PHAXIAM THERAPEUTICS SA: COMMERCIAL COURT OF LYON DECIDED TO OPEN A JUDICIAL RECEIVERSHIP PROCEDURE PHAXIAM THERAPEUTICS SA: OPERATIONS WILL CONTINUE DURING OBSERVATION PERIOD PHAXIAM THERAPEUTICS SA: TRADING SUSPENSION IS MAINTAINED Source text: ID:nBw5kWV25a Further company coverage: PHXM.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure